2017
DOI: 10.3892/ijo.2017.3866
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling

Abstract: Resveratrol is known to be an effective chemo-preventive phytochemical against multiple tumor cells. However, the increasing drug resistance avoids the cancer treatment in oral cavity cancer. In this study, we investigated the oral antitumor activity of resveratrol and its mechanism in cisplatin-resistant human oral cancer CAR cells. Our results demonstrated that resveratrol had an extremely low toxicity in normal oral cells and provoked autophagic cell death to form acidic vesicular organelles (AVOs) and auto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
136
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 170 publications
(141 citation statements)
references
References 55 publications
5
136
0
Order By: Relevance
“…(5) Pepstatin A inhibits lysosomal protein degradation. (6) Resveratrol induces autophagy through activation of AMPK and (7) Tunicamycin is a glycosylation inhibitor that induces autophagy [55, 90, 91]. …”
Section: Assays For Monitoring Autophagy and Pharmacological Regulatementioning
confidence: 99%
“…(5) Pepstatin A inhibits lysosomal protein degradation. (6) Resveratrol induces autophagy through activation of AMPK and (7) Tunicamycin is a glycosylation inhibitor that induces autophagy [55, 90, 91]. …”
Section: Assays For Monitoring Autophagy and Pharmacological Regulatementioning
confidence: 99%
“…For example, Torin1 and the mTOR inhibitor rapamycin can induce autophagy [22,23]. 3-Methyladenine (3-MA) blocks the formation of autophagosomes by inhibiting class III PI3K [24]. Bafilomycin A1 inhibits lysosome acidification and lysosome degradation by inhibiting V-ATPase.…”
Section: Introductionmentioning
confidence: 99%
“…However, surgery, radiotherapy and chemotherapy did not significantly improve the overall survival rate of oral cancer patients. On top of that, the development of drug resistance in the duration of chemotherapy remains as a clinical obstacle [18, 19]. To meet the need, designing novel compounds as well as discovering new targeting molecules that can overcome the resistance to chemotherapeutic drugs in oral cancer are clinically important.…”
Section: Introductionmentioning
confidence: 99%